Anzeige
Mehr »
Mittwoch, 13.05.2026 - Börsentäglich über 12.000 News
Bahnbrechende KI-Lösung "Ohne Nadelstiche" als Ersatz für herkömmliche Bluttests "unlocked"?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 905265 | ISIN: SE0000135485 | Ticker-Symbol: 27R
Tradegate
13.05.26 | 17:02
16,680 Euro
+3,47 % +0,560
Branche
Software
Aktienmarkt
Sonstige
1-Jahres-Chart
RAYSEARCH LABORATORIES AB Chart 1 Jahr
5-Tage-Chart
RAYSEARCH LABORATORIES AB 5-Tage-Chart
RealtimeGeldBriefZeit
16,63016,75019:14
16,63016,75019:14

Aktuelle News zur RAYSEARCH LABORATORIES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiRaySearch Laboratories AB: First online adaptive treatment on TrueBeam using RayStation and RayCare279RaySearch Laboratories AB (publ) is pleased to announce that Iridium Network in Belgium has successfully completed its first online adaptive radiation treatment using RayStation®* and RayCare®* on a...
► Artikel lesen
FrDividendenbekanntmachungen (08.05.2026)12.893 Unternehmen  ISIN-Code  Dividende (Währung)  Dividende (EUR)  ADDNODE GROUP AB  SE0017885767  1,15 SEK  0,1057 EUR  ADIDAS AG  DE000A1EWWW0 - 2,8 EUR  ALLIANCE RESOURCE PARTNERS LP  US01877R1086  0...
► Artikel lesen
DoRaySearch Laboratories AB: Bulletin from the Annual General Meeting 2026122The Annual General Meeting 2026 of RaySearch Laboratories AB (publ) was held on May 7, 2026 in Stockholm, Sweden. The following resolutions were adopted. It was resolved to re-elect Carl Filip Bergendal...
► Artikel lesen
29.04.RaySearch Laboratories AB: Interim report first quarter 2026: Strong long-term performance and raised margin target170FIRST QUARTER (JANUARY-MARCH 2026)Order intake decreased by 13% to SEK 356 M (410)Net sales decreased by 12% to SEK 290 M (332), with organic growth of -5 %Operating profit (EBIT) decreased by 10% to...
► Artikel lesen
27.04.RaySearch Laboratories AB: Institut Hartmann selects RayStation and RayCare150RaySearch Laboratories AB (publ) is pleased to announce that Institut de Radiothérapie et de Radiochirurgie Hartmann has selected RayStation ®* and RayCare®* to improve clinical workflows across a mixed...
► Artikel lesen
RAYSEARCH LABORATORIES Aktie jetzt für 0€ handeln
17.04.RaySearch Laboratories AB: RaySearch receives first RayCare order in China264RaySearch Laboratories (publ) has received an order for the treatment planning system RayStation®* and oncology information system RayCare®* from P-Cure. The systems will support P-Cure's proton therapy...
► Artikel lesen
19.03.RaySearch Laboratories AB: First patient treated in Ukraine using RayStation348RaySearch is proud to announce that the first patient has been successfully treated using RayStation at the Poltava Regional Cancer Clinic in Ukraine. This milestone, achieved in partnership with the...
► Artikel lesen
12.02.RaySearch Laboratories AB Ser. B Q4 Profit Advances10
12.02.RaySearch Laboratories AB: Year-end report 2025: Record revenue and strong earnings growth despite currency headwinds355FOURTH QUARTER (OCTOBER - DECEMBER 2025)Order intake increased by 8% to SEK 330 M (305)Net sales increased by 16% to SEK 375 M (323), with organic growth of 28%Operating profit (EBIT) strengthened by...
► Artikel lesen
07.11.25RaySearch Laboratories AB: Interim report third quarter 2025: Record high net sales and strong long-term performance388THIRD QUARTER (JULY - SEPTEMBER 2025)Order intake increased by 17% to SEK 295 M (253)Net sales increased by 13% to SEK 332 M (293), with organic growth of 19%Operating profit (EBIT) strengthened by...
► Artikel lesen
08.08.25RaySearch Laboratories AB: Interim report April - June 2025263SECOND QUARTER (APRIL - JUNE 2025) Order intake amounted to SEK 241.2 M (290.3) Net sales amounted to SEK 304.9 (318.9) Operating profit amounted to SEK 36.4 M (79.3) Profit after tax...
► Artikel lesen
11 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1